2026-2030年全球生物技術試劑市場

全球生物技術試劑市場預計將從 2025 年到 2030 年成長至 494.128 億美元，預測期內複合年成長率為 8.2%。

本報告對全球生物技術試劑市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動市場發展的因素包括：基因組學和蛋白​​質組學應用高精度試劑的產業化、生物製藥研發投入的增加、重組和細胞培養試劑架構的戰略性崛起、就地檢驗的成長以及即用型試劑組的普及。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的資訊。報告內容涵蓋主要企業分析、全面的市場規模數據、區域細分分析以及供應商格局。報告中包含歷史資料和預測資料。

本研究指出，人工智慧最佳化的試劑製備和預測穩定性建模將是未來幾年全球生物技術試劑市場成長的關鍵促進因素。此外，人源性檢測試劑的推出、動物性原料的逐步淘汰以及綠色化學和永續試劑生命週期管理的推廣，預計也將產生巨大的市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
• 輸入的重要性及差異化因素
• 混淆因素
• 促進因素和挑戰的影響

第3章 市場狀況

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場的定義
• 市場區隔分析
• 2025年市場規模
• 2025-2030年市場展望

第5章 市場規模與表現

• 2020-2024年全球生物技術試劑市場
• 2020-2024年技術細分市場分析
• 2020-2024年按應用領域分類的細分市場分析
• 2020-2024年產品細分市場分析
• 2020-2024年區域市場分析
• 2020-2024年各國細分市場分析

第6章 定性分析

• 人工智慧的影響：全球生物技術試劑市場
• 地緣政治衝突對全球生物技術試劑市場的影響

第7章：五力分析

• 五力模型概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 市場區隔：依技術分類

• 比較：按技術
• 層析法
• 體外診斷
• 聚合酵素鏈鎖反應
• 細胞培養
• 其他
• 市場機會：依技術分類

第9章 市場區隔：依應用

• 比較：透過應用
• 蛋白質合成與純化
• 基因表現
• DNA和RNA分析
• 藥物檢測
• 市場機會：依應用領域分類

第10章 市場區隔：依產品

• 比較：按產品
• 生命科學試劑
• 分析試劑
• 其他
• 市場機會：依產品分類

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 日本
  • 印度
  • 韓國
  • 泰國
  • 印尼
• 世界其他地區
  • 巴西
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 土耳其
  • 阿根廷
  • 哥倫比亞
  • 南非
  • 以色列
• 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 混亂局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 公司排名指標
• 企業市場定位
• Abbott Laboratories
• Agilent Technologies Inc.
• Beckman Coulter Inc.
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• BioMerieux SA
• F. Hoffmann La Roche Ltd.
• Lonza Group Ltd.
• Merck KGaA
• Meridian Bioscience Inc.
• Promega Corp.
• Revvity Inc.
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.

第16章附錄

The global biotechnology reagents market is forecasted to grow by USD 49412.8 mn during 2025-2030, accelerating at a CAGR of 8.2% during the forecast period. The report on the global biotechnology reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by industrialization of high-fidelity reagents for genomic and proteomic applications, increase in biopharmaceutical development spending and strategic rise of recombinant and cell-culture reagent architectures, growth of point-of-care testing and adoption of ready-to-use reagent kits.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global biotechnology reagents market is segmented as below:

By Technology

• Chromatography
• In-vitro diagnostics
• Polymerase chain reaction
• Cell culture
• Others

By Application

• Protein synthesis and purification
• Gene expression
• DNA and RNA analysis
• Drug testing

By Product

• Life science reagents
• Analytical reagents
• Others

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the formulation of ai-optimized reagent and predictive stability modeling as one of the prime reasons driving the global biotechnology reagents market growth during the next few years. Also, introduction of human-relevant testing reagents and strategic phase-out of animal-derived inputs and expansion of green chemistry and sustainable reagent life-cycle management will lead to sizable demand in the market.

The report on the global biotechnology reagents market covers the following areas:

• Global biotechnology reagents market sizing
• Global biotechnology reagents market forecast
• Global biotechnology reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global biotechnology reagents market vendors that include Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., BioMerieux SA, F. Hoffmann La Roche Ltd., Illumina Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., New England Biolabs Inc., Promega Corp., QIAGEN N.V., Revvity Inc., Siemens AG, Sysmex Corp., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp.. Also, the global biotechnology reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Biotechnology Reagents Market 2020 - 2024
  • Historic Market Size - Data Table on Global Biotechnology Reagents Market 2020 - 2024 ($ million)
• 5.2 Technology segment analysis 2020 - 2024
  • Historic Market Size - Technology Segment 2020 - 2024 ($ million)
• 5.3 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in global biotechnology reagents market
• 6.2 Impact of geopolitical conflict for global biotechnology reagents market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Technology

• 8.1 Market segments
• 8.2 Comparison by Technology
• 8.3 Chromatography - Market size and forecast 2025-2030
• 8.4 In-vitro diagnostics - Market size and forecast 2025-2030
• 8.5 Polymerase chain reaction - Market size and forecast 2025-2030
• 8.6 Cell culture - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Technology
  • Market opportunity by Technology ($ million)

9 Market Segmentation by Application

• 9.1 Market segments
• 9.2 Comparison by Application
• 9.3 Protein synthesis and purification - Market size and forecast 2025-2030
• 9.4 Gene expression - Market size and forecast 2025-2030
• 9.5 DNA and RNA analysis - Market size and forecast 2025-2030
• 9.6 Drug testing - Market size and forecast 2025-2030
• 9.7 Market opportunity by Application
  • Market opportunity by Application ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Life science reagents - Market size and forecast 2025-2030
• 10.4 Analytical reagents - Market size and forecast 2025-2030
• 10.5 Others - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 France - Market size and forecast 2025-2030
  • 12.4.3 UK - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 Japan - Market size and forecast 2025-2030
  • 12.5.3 India - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Industrialization of high-fidelity reagents for genomic and proteomic applications
  • Increase in biopharmaceutical development spending and strategic rise of recombinant and cell-culture reagent architectures
  • Growth of point-of-care testing and adoption of ready-to-use reagent kits
• 13.2 Market challenges
  • Disruption of global sourcing networks and implementation of bio-industrial security mandates
  • Complexity of regulatory harmonization amidst introduction of european biotech act
  • Structural cost inflation and fragility of cold-chain logistics for advanced biologics
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Formulation of AI-optimized reagent and predictive stability modeling
  • Introduction of Human-relevant testing reagents and strategic phase-out of animal-derived inputs
  • Expansion of green chemistry and sustainable reagent life-cycle management

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.6 Beckman Coulter Inc.
  • Beckman Coulter Inc. - Overview
  • Beckman Coulter Inc. - Product / Service
  • Beckman Coulter Inc. - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Bio Rad Laboratories Inc.
  • Bio Rad Laboratories Inc. - Overview
  • Bio Rad Laboratories Inc. - Business segments
  • Bio Rad Laboratories Inc. - Key news
  • Bio Rad Laboratories Inc. - Key offerings
  • Bio Rad Laboratories Inc. - Segment focus
  • SWOT
• 15.9 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key news
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 15.10 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 15.11 Lonza Group Ltd.
  • Lonza Group Ltd. - Overview
  • Lonza Group Ltd. - Business segments
  • Lonza Group Ltd. - Key news
  • Lonza Group Ltd. - Key offerings
  • Lonza Group Ltd. - Segment focus
  • SWOT
• 15.12 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.13 Meridian Bioscience Inc.
  • Meridian Bioscience Inc. - Overview
  • Meridian Bioscience Inc. - Product / Service
  • Meridian Bioscience Inc. - Key offerings
  • SWOT
• 15.14 Promega Corp.
  • Promega Corp. - Overview
  • Promega Corp. - Product / Service
  • Promega Corp. - Key offerings
  • SWOT
• 15.15 Revvity Inc.
  • Revvity Inc. - Overview
  • Revvity Inc. - Business segments
  • Revvity Inc. - Key offerings
  • Revvity Inc. - Segment focus
  • SWOT
• 15.16 Siemens AG
  • Siemens AG - Overview
  • Siemens AG - Business segments
  • Siemens AG - Key news
  • Siemens AG - Key offerings
  • Siemens AG - Segment focus
  • SWOT
• 15.17 Sysmex Corp.
  • Sysmex Corp. - Overview
  • Sysmex Corp. - Business segments
  • Sysmex Corp. - Key offerings
  • Sysmex Corp. - Segment focus
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations